A Randomized Controlled Trial Comparing Fat-free Versus Balanced (WHO) Diet in Gallstone Disease

NCT ID: NCT06405906

Last Updated: 2024-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

242 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-27

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this trial is to assess the effect on the quality of life (QoL) of recommending a fat-free diet versus a balanced WHO diet in symptomatic patients with gallstones and in patients undergoing cholecystectomy for gallstone disease. The main question it aims to answer is:

• Is balanced WHO diet as good as low-fat diet in terms of patient reported outcomes when gallstone disease is managed non-operatively (RADIGAL-1) or cholecystectomy is performed (RADIGAL-2)?

A validated QoL questionnaire (Gastrointestinal Quality of Life Index - GIQLI) will be administered both at baseline and during follow-up. Analysis of covariance with ordinary least squares estimation will be applied to estimate between-group differences in GIQLI scores at 3 months (primary endpoint). Patient adherence and the disease-related symptoms occurrence or hospitalizations will also be appraised (secondary endpoint).

Participants presenting with biliary colic or acute cholecystitis (RADIGAL-1) or undergoing cholecystectomy for gallstones (RADIGAL-2) will:

* be randomly assigned to recommending either a fat-free or a balanced WHO diet .
* be contacted via phone call to complete the GIQLI questionnaire and document overall adherence to the diets and secondary outcome events.

This trial examines the impact of diet on adverse events in gallstone disease, representing the first randomized study to focus on this aspect.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gallstone Disease Gallstone; Colic Gallstone; Cholecystitis, Acute Cholelithiases Postcholecystectomy Syndrome Dietary Habits

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Biliary Colic Group - Non-operative Treatment - RADIGAL1

Patients presenting with biliary colic and treated non-operatively will be randomly assigned to receive fat-free diet or balanced WHO diet for 3 months.

Group Type EXPERIMENTAL

Fat-free diet

Intervention Type OTHER

The low-fat diet will consist of instructions to avoid fatty foods.

Balanced WHO diet

Intervention Type OTHER

The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025

Cholecystitis Group - Non-operative Treatment - RADIGAL1

Patients presenting with acute cholecystitis and treated non-operatively will be randomly assigned to receive fat-free diet or balanced WHO diet for 3 months.

Group Type EXPERIMENTAL

Fat-free diet

Intervention Type OTHER

The low-fat diet will consist of instructions to avoid fatty foods.

Balanced WHO diet

Intervention Type OTHER

The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025

Biliary Colic Group - Cholecystectomy - RADIGAL2

Patients undergoing cholecystectomy due to biliary colic will be randomly assigned to receive fat-free diet or balanced diet for 3 months.

Group Type EXPERIMENTAL

Fat-free diet

Intervention Type OTHER

The low-fat diet will consist of instructions to avoid fatty foods.

Balanced WHO diet

Intervention Type OTHER

The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025

Cholecystitis Group - Cholecystectomy - RADIGAL2

Patients undergoing cholecystectomy due to acute cholecystitis will be randomly assigned to receive fat-free diet or balanced diet for 3 months.

Group Type EXPERIMENTAL

Fat-free diet

Intervention Type OTHER

The low-fat diet will consist of instructions to avoid fatty foods.

Balanced WHO diet

Intervention Type OTHER

The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fat-free diet

The low-fat diet will consist of instructions to avoid fatty foods.

Intervention Type OTHER

Balanced WHO diet

The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years old or older
* presenting with biliary colic in the ED or outpatient clinic, with the surgical team deciding to proceed with non-operative treatment (Group 1)
* presenting with acute calculous cholecystitis in the ED, with the surgical team deciding to proceed with non-operative management (Group 2)


* 18 years old or older
* undergoing uncomplicated cholecystectomy (open or laparoscopic without bile duct exploration) due to a history of biliary colic (Group 1)
* undergoing uncomplicated cholecystectomy (open or laparoscopic without bile duct exploration) due to acute cholecystitis (Group 2)

Exclusion Criteria

* history of gastrointestinal disease which might affect diet, e.g., inflammatory bowel disease, irritable bowel syndrome, short bowel syndrome
* inability to provide informed consent
* unwillingness to adhere to the recommended diet
* food allergies or intolerances that would prevent following the diet
* dietary habits (e.g., vegetarians, vegans) that preclude adherence to the recommended diet
* gallstone related cholangitis without biliary colic or cholecystitis
* complications from acute pancreatitis, such as pseudocysts, walled off necrosis, among others


* history of gastrointestinal disease which might affect diet, e.g., inflammatory bowel disease, irritable bowel syndrome, short bowel syndrome
* inability to provide informed consent
* unwillingness to adhere to the recommended diet
* food allergies or intolerances that would prevent following the diet - dietary habits (e.g., vegetarians, vegans) that preclude adherence to the recommended diet
* gallstone related cholangitis without biliary colic or cholecystitis
* complications from acute pancreatitis, such as pseudocysts, walled off necrosis, among others
* choledocholithiasis
* complicated cholecystectomy
* patients undergoing subtotal cholecystectomy
* whether primary operation differs from cholecystectomy (e.g., colectomy)
* patients having treated with percutaneous cholecystostomy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital of Crete

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Konstantinos Lasithiotakis

Assistant Professor of Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Konstantinos Lasithiotakis, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Surgery, University Hospital of Heraklion

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Surgery, University Hospital of Heraklion

Heraklion, , Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Konstantinos Lasithiotakis, MD, PhD

Role: CONTACT

00302810392677

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Konstantinos Lasithiotakis

Role: primary

00302810392677

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5414/27-03-2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.